Conference
Improved prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma.
Abstract
311
Background: Previously identified prognostic factors in patients (pts) receiving salvage systemic therapy for advanced urothelial carcinoma (UC) include performance status (PS), liver metastasis (LM), hemoglobin (Hb) and time from prior chemotherapy (TFPC). Given the prognostic impact of peripheral blood neutrophils (N), lymphocytes (L), thrombocytes (T) and albumin (Alb) in other malignancies, we investigated their impact …
Authors
Sonpavde G; Pond GR; Rosenberg JE; Bajorin DF; Regazzi AM; Choueiri TK; Mullane SA; Niegisch G; Albers P; Necchi A
Volume
33
Pagination
pp. 311-311
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 1, 2015
DOI
10.1200/jco.2015.33.7_suppl.311
Conference proceedings
Journal of Clinical Oncology
Issue
7_suppl
ISSN
0732-183X